Search
Descriptor English: Mesalamine
Descriptor Spanish: Mesalamina
Descriptor mesalamina
Entry term(s) 5-aminosaliciliato
mesalacina
Scope note: Antiinflamatorio relacionado estructuralmente con los SALICILATOS, que es activo en la ENFERMEDAD INFLAMATORIA INTESTINAL. Se considera que es la porción activa de la SULFASALACINA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Descriptor Portuguese: Mesalamina
Descriptor French: Mésalazine
Entry term(s): 5 Aminosalicylate
5 Aminosalicylic Acid
5-Aminosalicylate
5-Aminosalicylic Acid
Asacol
Asacolon
Ascolitin
Canasa
Claversal
Fivasa
Hydrochloride, Mesalamine
Lixacol
Mesalamine Hydrochloride
Mesalamine Monosodium Salt
Mesalazine
Mesasal
Monosodium Salt, Mesalamine
Novo 5 ASA
Novo-5 ASA
Pentasa
Rowasa
Salofalk
m Aminosalicylic Acid
m-Aminosalicylic Acid
meta Aminosalicylic Acid
meta-Aminosalicylic Acid
Tree number(s): D02.241.223.100.050.300.500
D02.241.223.100.300.595.100.540
D02.241.511.390.595.100.540
D02.455.426.559.389.127.020.452.750
D02.455.426.559.389.127.281.595.100.540
D02.455.426.559.389.657.410.595.100.540
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D019804
Scope note: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Entry Combination: analogs & derivatives:Aminosalicylic Acids
Pharm Action: Anti-Inflammatory Agents, Non-Steroidal
Registry Number: 4Q81I59GXC
Previous Indexing: Aminosalicylic Acids (1981-1997)
Public MeSH Note: 98; MESALAMINE was indexed under AMINOSALICYLIC ACIDS 1981-97
History Note: 98; use MESALAMINE (NM) 1981-97
DeCS ID: 33400
Unique ID: D019804
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1998/01/01
Date of Entry: 1997/06/20
Revision Date: 2017/01/17
Mesalamine - Preferred
Concept UI M0029386
Scope note An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
Preferred term Mesalamine
Entry term(s) 5 Aminosalicylic Acid
5-Aminosalicylic Acid
Mesalazine
m Aminosalicylic Acid
m-Aminosalicylic Acid
meta Aminosalicylic Acid
meta-Aminosalicylic Acid
Asacol - Narrower
Concept UI M0029389
Preferred term Asacol
Asacolon - Narrower
Concept UI M0474818
Preferred term Asacolon
Ascolitin - Narrower
Concept UI M0474817
Preferred term Ascolitin
Canasa - Narrower
Concept UI M0474819
Preferred term Canasa
Claversal - Narrower
Concept UI M0029391
Preferred term Claversal
Fivasa - Narrower
Concept UI M0474826
Preferred term Fivasa
Salofalk - Narrower
Concept UI M000623474
Preferred term Salofalk
Lixacol - Narrower
Concept UI M0474827
Preferred term Lixacol
Mesalamine Hydrochloride - Narrower
Concept UI M0329125
Preferred term Mesalamine Hydrochloride
Entry term(s) Hydrochloride, Mesalamine
Mesalamine Monosodium Salt - Narrower
Concept UI M0329124
Preferred term Mesalamine Monosodium Salt
Entry term(s) Monosodium Salt, Mesalamine
Mesasal - Narrower
Concept UI M0029392
Preferred term Mesasal
Novo-5 ASA - Narrower
Concept UI M0474828
Preferred term Novo-5 ASA
Entry term(s) Novo 5 ASA
Pentasa - Narrower
Concept UI M0029388
Preferred term Pentasa
Rowasa - Narrower
Concept UI M0029393
Preferred term Rowasa
5-Aminosalicylate - Narrower
Concept UI M0029385
Preferred term 5-Aminosalicylate
Entry term(s) 5 Aminosalicylate



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey